Predictive oncology announces ceo retirement

Eagan, minn., sept. 16, 2022 (globe newswire) -- predictive oncology (nasdaq: poai) today announced that j. melville (“mel”) engle will retire as chief executive officer and as chairman and a member of the company's board of directors. to ensure a smooth transition of his responsibilities, mr. engle will continue to serve in his role through october 31, 2022. pursuant to policies regarding leadership succession, the governance committee of poai's board of directors is working with a succession plan to replace mr. engle as chief executive officer.
POAI Ratings Summary
POAI Quant Ranking